Radiolabeled Quercetin Preferentially Targets Bacterial Infection Sites in Animal Models
A preclinical feasibility study demonstrates that technetium-99m-labeled quercetin achieves high radiochemical yield and preferentially accumulates at Escherichia coli infection sites ...

